WebSYRS : 1.0200 (-5.56%) Syros to Report First Quarter 2024 Financial Results on Monday, May 16, 2024 Business Wire - Mon May 9, 6:30AM CDT. Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that it will host a live conference call and webcast at 8:30 a.m. ET... WebSyros Pharmaceuticals…. Syros Pharmaceuticals presents safety lead-in data from SELECT-AML-1 trial » 12/11/22. SYRS. Syros Pharmaceuticals…. Syros Pharmaceuticals price target lowered to $16 from $40 at JMP Securities » 11/15/22. SYRS. JMP Securities analyst…. Syros Pharmaceuticals price target lowered to $15 from $30 at Oppenheimer ...
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Given Average …
WebMar 31, 2024 · Current Quarter Estimates for SYRS. In the past 30 days, one estimate has gone higher for Syros Pharmaceuticals while no estimates have gone lower in the same time period. The trend has been pretty favorable too, with estimates increasing from a loss of 70 cents a share 30 days ago, to a loss of 61 cents today, a move of 13%. WebSyros Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update. CAMBRIDGE, Mass., March 02, 2024--Syros Pharmaceuticals (NASDAQ:SYRS), a … trigent software gd topics
SYRS - Syros Pharmaceuticals Stock Price - Barchart.com
WebMar 29, 2024 · Get Syros Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SYRS and its competitors with MarketBeat's FREE … WebApr 10, 2024 · Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of 38.36% and 21.65%, respectively, for the quarter ended September 2024. Do the … WebSyros Pharmaceuticals Inc. (SYRS) Stock Price Today, News, Quotes, FAQs and Fundamentals DIA 0.42% SPY 0.17% QQQ 0.55% Trending RIOT 14.56% AUPH 10.18% … trigent software chennai